MAP2 and central nervous system cancer: MAP2 cellular pattern of immunolabeling: All oligodendrogliomas (53/53; 100%) and undefined gliomas (12/12; 100%) had a combination of PNc and Ct staining (Figures 1C–F, 3C–F).